Symbicort and Breathing difficulty - a phase IV clinical study of FDA data

Summary:

Breathing difficulty is found among people who take Symbicort, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Symbicort and have Breathing difficulty. It is created by eHealthMe based on reports of 97,511 people who have side effects when taking Symbicort from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 09, 2023

97,511 people reported to have side effects when taking Symbicort.
Among them, 20,576 people (21.1%) have Breathing difficulty.

What is Symbicort?

Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 99,537 Symbicort users for its effectiveness, alternative drugs and more.

What is Breathing difficulty?

Breathing difficulty is found to be associated with 5,084 drugs and 5,948 conditions by eHealthMe.

Number of Symbicort and Breathing difficulty reports submitted per year:

Could Symbicort cause Breathing difficulty?

* Approximation only. Some reports may have incomplete information.

Do you take Symbicort and have Breathing difficulty?

Check whether Breathing difficulty is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Breathing difficulty and when was it recovered:

Breathing difficulty in Symbicort

Expand to all the drugs that have ingredients of budesonide; formoterol fumarate dihydrate:

Breathing difficulty and drugs with ingredients of budesonide; formoterol fumarate dihydrate (17,456 reports)

Alternative drugs to, pros and cons of Symbicort:

Symbicort (99,537 reports)

Common Symbicort side effects:

Breathing difficulty: 20,576 reports
Asthma: 14,357 reports
Cough: 9,475 reports
Wheezing (a high-pitched whistling sound made while you breath): 7,274 reports
Pneumonia: 7,067 reports
Fatigue (feeling of tiredness): 6,886 reports
Drug ineffective: 6,678 reports
Malaise (a feeling of general discomfort or uneasiness): 6,630 reports
Chest pain: 6,000 reports

Browse all side effects of Symbicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Breathing difficulty treatments and more:

Breathing difficulty (579,790 reports)

COVID vaccines that are related to Breathing difficulty:

Common drugs associated with Breathing difficulty:

All the drugs that are associated with Breathing difficulty:

Breathing difficulty (5,084 drugs)

Common conditions associated with Breathing difficulty:

Asthma: 40,041 reports
Primary pulmonary hypertension: 34,524 reports
High blood pressure: 26,686 reports
Rheumatoid arthritis: 25,046 reports
Chronic obstructive pulmonary disease: 24,688 reports
Pain: 15,332 reports

All the conditions that are associated with Breathing difficulty:

Breathing difficulty (5,948 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide; formoterol fumarate dihydrate (the active ingredients of Symbicort) and Symbicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.